search
Back to results

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Primary Purpose

Colonic Neoplasms, Rectal Neoplasms

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
First-Line Bevacizumab and Chemotherapy
Bevacizumab
Sponsored by
King Faisal Specialist Hospital & Research Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colonic Neoplasms focused on measuring Colon and Rectum Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with metastatic cancer of colon or rectum

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Effectiveness

    Secondary Outcome Measures

    Quality of life

    Full Information

    First Posted
    October 1, 2007
    Last Updated
    December 16, 2015
    Sponsor
    King Faisal Specialist Hospital & Research Center
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00537901
    Brief Title
    First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
    Official Title
    First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    October 2007 (undefined)
    Primary Completion Date
    October 2013 (Actual)
    Study Completion Date
    October 2013 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    King Faisal Specialist Hospital & Research Center

    4. Oversight

    5. Study Description

    Brief Summary
    First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Colonic Neoplasms, Rectal Neoplasms
    Keywords
    Colon and Rectum Cancer

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    100 (Actual)

    8. Arms, Groups, and Interventions

    Intervention Type
    Radiation
    Intervention Name(s)
    First-Line Bevacizumab and Chemotherapy
    Intervention Description
    Chemotherapy
    Intervention Type
    Drug
    Intervention Name(s)
    Bevacizumab
    Intervention Description
    Chemotherapy
    Primary Outcome Measure Information:
    Title
    Effectiveness
    Time Frame
    overall
    Secondary Outcome Measure Information:
    Title
    Quality of life
    Time Frame
    overall

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with metastatic cancer of colon or rectum
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Shouki Bazarbashi, MD
    Organizational Affiliation
    KFSH & RC
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

    We'll reach out to this number within 24 hrs